Verici Dx plc (LON:VRCI – Get Free Report)’s share price rose 18.1% during trading on Thursday . The company traded as high as GBX 0.74 and last traded at GBX 0.74. Approximately 2,540,138 shares were traded during mid-day trading, an increase of 32% from the average daily volume of 1,930,567 shares. The stock had previously closed at GBX 0.63.
Verici Dx Stock Performance
The firm’s 50 day moving average price is GBX 0.67 and its 200-day moving average price is GBX 0.93. The firm has a market cap of £11.20 million, a price-to-earnings ratio of -0.26 and a beta of 1.59. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Further Reading
- Five stocks we like better than Verici Dx
- What Are Earnings Reports?
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- How to Evaluate a Stock Before Buying
- Why Vertical Aerospace Stock Could Double After This Flight Test
- Transportation Stocks Investing
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
